Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol versus dexmedetomidine during electroconvulsive therapy
PACTR202402621085427Not yet recruiting
- Sponsor
- Self-Funded Health
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of propofol and dexmedetomidine in mental disorder (2 arms), sponsored by Self-Funded Health. Primary endpoint: Mean arterial pressure changes at 1 minute. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
propofoldexmedetomidine
03
Conditions
mental disorder
Beyond the preview
Go deeper on PACTR202402621085427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202402621085427.